Development of a novel cyclic peptide drug to inhibit MyD88 as a key signalling molecule in innate immunity, with application to autoimmune central nervous system disease
Autoimmune disease, Inflammation, Oncology
Superactive High Afinity Leptin antagonist, mutein, multiple sclerosis, inflammatory bowel syndrome, rheumatoid arthritis, fibrosis, cardiovascular disease, CKD Cachexia, Osteoarthritis
(1) In vivo tests in animal ...
Antigen and/or organic adjuvant entrapped within alumina adjuvant
Antibodies, Vaccinations, Drug delivery, Immunology, Adjuvants, Alumina
In vivo proof of concept
Provisional patent filed in the ...
New approaches to developing reagents that block cancers' support mechanism
Life Sciences and Biotechnology, MedicineProfessor Ben Neriah's Laboratory for Immunology and Cancer Research, The Lautenberg Center for General and Tumor ...
Immunomodulatory peptides derived from Japanese rice
Peptide, Small Molecule, Inflammatory/Autoimmune diseases
Proof of concept in MS mouse model
Patent filed in the United States